Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of
incorporation) |
(Commission File Number)
|
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
(Former name or former address, if changed since last report)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which
registered
|
||
|
|
The
|
(d)
|
Exhibits:
|
99.1
|
104
|
Cover Page Interactive Data File (embedded withing the Inline XBRL document)
|
DATE: May 28, 2025
|
|
Mesa Laboratories, Inc.
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
BY:
|
/s/ Gary M. Owens
|
|
|
|
Gary M. Owens
|
|
|
|
President and Chief Executive Officer
|
|